Tender Overview
The Border Security Force (BSF) invites bids for a comprehensive pharmaceutical and medical consumables package, spanning 24 listed items that include eye drops, ear drops, syrups, tablets, injections, and IV supplies. The procurement targets a diverse set of therapeutic categories, with emphasis on brand verification and expiry management. The BOQ references 24 items with non-disclosed unit quantities, while the bidder must align with the buyer’s brand preference and ATC/GST compliance. The tender’s scope includes adherence to the option clause allowing up to 25% quantity variation, and a flexible delivery timeline anchored to original delivery periods. This procurement is governed by buyer-added terms under Central Armed Police Forces and is critical for ongoing medical readiness.
The organization emphasizes medicine brand verification, GST/ATC certificate submission, and expiry management, signaling strict quality controls. The tender highlights the possibility of quantity variation during contract execution and requires bidders to comply with extended delivery calculations. The scope is broad, covering anti-infectives, cardiovasculars, bronchodilators, vitamins, electrolyte solutions, and anesthesia-therapy references, making supplier qualification and supply chain reliability essential. The procurement is positioned within the BSF medical supply ecosystem, with a focus on timely delivery and brand-specific approvals.
Keywords and compliance indicators include brand-specific medicines, expiry safeguards, GST/ATC documentation, and adherence to delivery extension calculations. Bidders should prepare to demonstrate capability for multi-item pharmaceutical supply, regulatory alignment, and a robust cold-chain or storage plan where applicable, ensuring readiness for urgent medical deployments in the field.
Technical Specifications & Requirements
- 24 medical items listed, including eye/ear drops, syrups, tablets, injections, and IV supplies; exact unit quantities not disclosed in BOQ.
- Mandatory brand verification and expiry management per ATC/ISMS guidelines; medicines with imminent expiry within 12 months may be disallowed.
- GST registration and ATC certificates required; GST impact will be reimbursed at actuals or capped to quoted GST rate.
- Delivery terms reference an option clause allowing up to 25% quantity variation during and after contract, with delivery period recalculation formula: (Increased quantity ÷ Original quantity) × Original delivery period, min 30 days.
- Bidders must upload GST certificate and ATC certificate; brand name referenced in bid must be accepted by the purchaser.
- Medicines must meet buyer-specified brand criteria; non-acceptance applies to expiry risk.
- 24 items imply a broad pharmacopoeial scope, including syrups, eye/ear drops, injectables, and tablets with associated storage requirements.
- No explicit EMD amount provided in the tender data; bidders should anticipate standard EMD practice per buyer terms.
- The tender is governed by Backend Terms and Conditions of Central Armed Police Forces with additional clauses on GST and brand acceptance.
Terms, Conditions & Eligibility
- EMD: Not specified in the provided data; bidders should locate and submit as per buyer's standard practice.
- Experience: Not explicitly stated; bidders should demonstrate capability for multi-item pharmaceutical procurement and supply chain reliability.
- Delivery: Extended delivery time can be calculated via the option clause; min 30 days after extended period.
- Payment: GST reimbursement governed by actuals or applicable rates; payment terms align with buyer standard procedures.
- Documents: GST certificate, ATC certificate, brand documentation, and supplier identifiers to be uploaded with bid.
- Brand Acceptance: Medicines brand mentioned in bid must be accepted by BSF; expiry risk must be avoided.
- Expiry Rules: Medicines not accepted if expiry near within 12 months; ensure product lifecycle compliance.
- Compliance: Adhere to 1) brand verification, 2) expiry safeguards, 3) delivery-time calculations, and 4) regulatory documentation submission.
